Long-Term Treatment With Extended-Release Methylphenidate Treatment in Children Aged 4 to <6 Years

Long-Term Treatment With Extended-Release Methylphenidate Treatment in Children Aged 4 to <6 Years

To investigate long-term (12-month) safety and symptom control of extended-release methylphenidate (MPH-MLR) in children aged 4 to

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Academy of Child and Adolescent Psychiatry 2022-01, Vol.61 (1), p.80-92
Hauptverfasser: Childress, Ann C., Foehl, Henry C., Newcorn, Jeffrey H., Faraone, Stephen V., Levinson, Benjamin, Adjei, Akwete L.
Format: Artikel
Sprache:eng
Schlagworte:
ADHD
Attention Deficit Disorder with Hyperactivity - drug therapy
Central Nervous System Stimulants - adverse effects
Child
Child, Preschool
Delayed-Action Preparations
Dose-Response Relationship, Drug
Double-Blind Method
Humans
methylphenidate
Methylphenidate - adverse effects
preschool children
safety
Sleep Quality
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To investigate long-term (12-month) safety and symptom control of extended-release methylphenidate (MPH-MLR) in children aged 4 to
ISSN:0890-8567
1527-5418
DOI:10.1016/j.jaac.2021.03.019